1,6-Dibromohexane

We are 1,6-Dibromohexane CAS:629-03-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1,6-Dibromohexane
CAS.NO:629-03-8
Synonyms:Hexamethylene Bromide
1,6-Dibromohexan
Hexane, 1,6-dibromo-
HEXANE,1,6-DIBROMO
hexamethylene dibromide
Molecular Formula:C6H12Br2 
Molecular Weight:243.96700
 
Physical and Chemical Properties:
Density:1.586
Melting point:-2ºC
Boiling point:243ºC
Flash point:110ºC
Index of Refraction:1.507
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay(GC):≥99.0%
Moisture:≤0.1%
 
Packing:250 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

1,6-Dibromohexane


Related News: Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.34552-16-4 From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.2713-34-0 Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.1001911-63-2 Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.

Related Products
Product Name
Perchloromethylmercaptan View Details
2-Amino-3-hydroxypyridine View Details
5-(Trifluoromethyl)picolinonitrile View Details
5-(Trifluoromethyl)picolinonitrile manufacturer 1,2-Bis(triethoxysilyl)ethane manufacturer 1,10-Diiododecane manufacturer 4-AMINO-2-FLUOROBENZOIC ACID manufacturer 3-Methyl-5-nitropyridin-2-ol manufacturer